(Q28367098)

2

0 references

W W Nichols

3

0 references

C J Pepine

4

0 references

C R Conti

Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin

5

0 references

language of work or name

English

0 references

publication date

May 1980

0 references

published in

British Heart Journal

0 references

volume

43

0 references

issue

5

0 references

page(s)

556-60

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482341

Measurement of blood flow by thermodilution

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482341

Beneficial effects of hydralazine in severe mitral regurgitation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482341

Aortic input impedance during nitroprusside infusion. A reconsideration of afterload reduction and beneficial action

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482341

Vasodilator therapy of cardiac failure: (first of two parts)

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482341

The role of vasodilator therapy in heart failure

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482341

Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482341

Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvar apparatus.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482341

Effect of nitroprusside on left ventricular dynamics in mitral regurgitation.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482341

Afterload reduction therapy with nitroprusside in severe aortic regurgitation: improved cardiac performance and reduced regurgitant volume

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482341

Nitroprusside therapy in acute and chronic coronary heart disease

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482341

Improved left ventricular function during nitroprusside infusion in acute myocardial infarction

2 June 2018

1 reference

12 December 2020

Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance

1 reference

12 December 2020

Vasodilators in the Treatment of Heart Failure

1 reference

12 December 2020

Comparative hemodynamic effects of intravenous nitroprusside and oral prazosin in refractory heart failure

1 reference

12 December 2020

Aortic input impedance in heart failure

1 reference

12 December 2020

Clinical pharmacology and therapeutic application of prazosin in acute and chronic refractory congestive heart failure. Balanced systemic venous and arterial dilation improving pulmonary congestion and cardiac output

1 reference

12 December 2020

Afterload as a primary determinat of ventricular performance

1 reference

12 December 2020